Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Thomas Sinegre"'
Autor:
Sylvain Lamoine, Vincent Jury, Virginie Fourneyron, Jonathan Douxfils, Dorian Teissandier, Laurie Talon, Thomas Sinegre, Aurélien Lebreton
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102576- (2024)
Background: The incidence of cardiovascular diseases is increasing in persons with hemophilia A (HA). Therefore, anticoagulant therapy based on direct oral anticoagulants (DOACs) may be needed, despite the bleeding risk. In case of surgery or bleedin
Externí odkaz:
https://doaj.org/article/cd2213ce0bf847a7b9aadd36b2934e9d
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French Working Group on Hae
Externí odkaz:
https://doaj.org/article/604eef83f50949788af993219f4ceef7
Autor:
Laurie Talon, Virginie Fourneyron, Alexandre Trapani, Bruno Pereira, Thomas Sinegre, Aurélien Lebreton
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background The routine D‐dimer quantification to exclude venous thromboembolism has led to the development of many assays, the usefulness of which depends on their reliability and performance. Objective We evaluated the analytical performa
Externí odkaz:
https://doaj.org/article/e82e76e578504f0fb58181bad55b7a25
Autor:
Thomas Sinegre, Cédric Duron, Thomas Lecompte, Géraldine Lamblin, Laurie Talon, Léon Muti, Sylvie Massoulier, Bruno Pereira, Aurélien Lebreton, Armand Abergel
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1441-1452
Publikováno v:
Seminars in Thrombosis and Hemostasis
Seminars in Thrombosis and Hemostasis, Thieme Publishing, 2020, 46 (06), pp.693-703. ⟨10.1055/s-0040-1715102⟩
Seminars in thrombosis and hemostasis, 46(6), 693-703. THIEME MEDICAL PUBL INC
Seminars in Thrombosis and Hemostasis, 2020, 46 (06), pp.693-703. ⟨10.1055/s-0040-1715102⟩
Seminars in Thrombosis and Hemostasis, Thieme Publishing, 2020, 46 (06), pp.693-703. ⟨10.1055/s-0040-1715102⟩
Seminars in thrombosis and hemostasis, 46(6), 693-703. THIEME MEDICAL PUBL INC
Seminars in Thrombosis and Hemostasis, 2020, 46 (06), pp.693-703. ⟨10.1055/s-0040-1715102⟩
Epidemiological and laboratory studies performed in the last decades have changed our understanding of coagulopathy in cirrhosis, from a condition at increased risk of hemorrhagic events to one at higher thrombotic risk. However, it is not clear whet
Autor:
Marion Gaudard, Elodie Boissier, Laurie Talon, Jonathan Douxfils, Anne‐Françoise Sapin, Thomas Sinegre, Aurélien Lebreton
Publikováno v:
International Journal of Laboratory Hematology
International Journal of Laboratory Hematology, Wiley, 2022, 44 (3), pp.610-618. ⟨10.1111/ijlh.13794⟩
International Journal of Laboratory Hematology, Wiley, 2022, 44 (3), pp.610-618. ⟨10.1111/ijlh.13794⟩
INTRODUCTION: Sample freezing is a part of routine laboratory tasks because some coagulation parameters are analysed in batches to optimize reagent consumption. The coagulation parameter stability in fresh and frozen samples has been described, but d
Autor:
Stéphanie Senectaire, Anne-Françoise Sapin, Thomas Sinegre, Alexandre Trapani, Virginie Fourneyron, Aurélien Lebreton, Adeline Trayaud, Laurie Talon, Aurélie Vaissade, Maxence Tillier, Maryse Tardieu
Publikováno v:
Annales de biologie clinique. 78(6)
Exploring coagulation in newborns and children is a challenge due to the low levels of both procoagulant factors and inhibitors. Conventional coagulation tests might be inadequate to explore all of these changes. The aim of the study is to evaluate t
Autor:
Mathilde Hunault Berger, A.-F. Sapin, Thomas Sinegre, A. Lebreton, L. Talon, B. de Renzis, Laurence Sanhes, M. Fiore
Publikováno v:
La Revue De Médecine Interne
La Revue De Médecine Interne, Elsevier, 2020, 41, pp.552-558. ⟨10.1016/j.revmed.2020.03.012⟩
La Revue de Médecine Interne
La Revue de Médecine Interne, 2020, 41, pp.552-558. ⟨10.1016/j.revmed.2020.03.012⟩
La Revue De Médecine Interne, Elsevier, 2020, 41, pp.552-558. ⟨10.1016/j.revmed.2020.03.012⟩
La Revue de Médecine Interne
La Revue de Médecine Interne, 2020, 41, pp.552-558. ⟨10.1016/j.revmed.2020.03.012⟩
Resume Introduction La leucemie chronique a neutrophiles (LCN) est un syndrome myeloproliferatif rare caracterise par une production importante de polynucleaires neutrophiles matures. L'une des complications les plus severes est la survenue d'eveneme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c771d9bde57bb46e969d45bebbf15fe
https://hal.archives-ouvertes.fr/hal-03492194
https://hal.archives-ouvertes.fr/hal-03492194
Autor:
Dragan Milenkovic, Thomas Sinegre, Pauline Fully, Christine Morand, Julien Bourdin, Dorian Teissandier, Aurélien Lebreton
Publikováno v:
European Journal of Pharmacology
European Journal of Pharmacology, Elsevier, 2021, 893, pp.173830. ⟨10.1016/j.ejphar.2020.173830⟩
European Journal of Pharmacology, 2021, 893, pp.173830. ⟨10.1016/j.ejphar.2020.173830⟩
European Journal of Pharmacology, Elsevier, 2021, 893, pp.173830. ⟨10.1016/j.ejphar.2020.173830⟩
European Journal of Pharmacology, 2021, 893, pp.173830. ⟨10.1016/j.ejphar.2020.173830⟩
International audience; Fibrin clot structure and function are major determinants of thromboembolic diseases. The study aim was to determine the impact of epicatechin (a flavonoid with cardiovascular protective effects) on fibrin clot structure and p
Autor:
Marc G. Berger, Maxence Tillier, Aurélie Vaissade, Anne‐Lise Barbin, Thomas Sinegre, Maryse Tardieu, Laurie Talon, Stéphanie Senectaire, Virginie Fourneyron, Aurélien Lebreton, Piotr Gembara, Adeline Trayaud
Publikováno v:
Haemophilia
Haemophilia, Wiley, 2020, 26 (3), pp.543-552. ⟨10.1111/hae.14003⟩
Haemophilia, Wiley, 2020, 26 (3), pp.543-552. ⟨10.1111/hae.14003⟩
International audience; Introduction Recombinant factor IX Fc fusion protein (rFIXFc) is an extended half-life concentrate for the treatment of haemophilia B (HB). rFIXFc activity monitoring is crucial in several clinical situations. However, differe